Clinical Trial Update: Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Topotecan plus Cisplatin to Etoposide plus Carboplatin in first-line extensive-disease small cell lung cancer; the study status is TERMI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Topotecan (topotecan)

Snippet

Sponsor: Danish Oncological Lung Cancer Group | Conditions: Extensive Disease, First-Line | Phase 3 | Status: TERMINATED